Skip to main content
Log in

Berberine attenuates hyperalgesia in mice with adenomyosis

  • General Gynecology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

Adenomyosis is a common gynecological disease, but its pathogenesis and treatment options are not yet completely clear. This study aimed to investigate the analgesic effect of berberine on tamoxifen-induced neonatal mouse adenomyosis and its curative effects on the disease.

Methods

The mouse adenomyosis model was established in neonatal female mice via oral administration of tamoxifen suspended solution. Adenomyosis mice were given berberine by intraperitoneal injection with the dosage of 5, 10, and 20 mg/kg body weight, respectively, at 17 weeks after birth. The pain sensation of the mice was evaluated by hotplate and tail-flick tests. The mRNA levels of gene expression were detected by RT-qPCR. The protein expression was analyzed by ELISA and Western blot.

Results

Berberine reduced the uterine weight, suppressed the myometrial infiltration of ectopic endometrium, improved the hotplate and tail-flick latency of the adenomyosis mice. Mechanistically, berberine downregulated the expression of genes related to pain and inflammation, such as TRPV1, COX-2, VEGF and OTR, impaired the inflammatory response at the DRG site, and inhibited the expression of TLR4 in DRG and uterine tissues.

Conclusions

Berberine attenuates hyperalgesia and exhibits analgesic and therapeutic effects on adenomyosis mice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

Data availability

The data supporting the results of this article are included within the article. Further enquiries can be directed to the corresponding author.

Code availability

Not applicable.

References

  1. Guo J, Chen L, Luo N, Li C, Chen R, Qu X, Liu M, Kang L, Cheng Z (2016) LPS/TLR4-mediated stromal cells acquire an invasive phenotype and are implicated in the pathogenesis of adenomyosis. Sci Rep 6:21416. https://doi.org/10.1038/srep21416

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Di Donato N, Seracchioli R (2014) How to evaluate adenomyosis in patients affected by endometriosis? Minim Invasive Surg 2014:507230. https://doi.org/10.1155/2014/507230

    Article  PubMed  PubMed Central  Google Scholar 

  3. Korzekwa A, Lupicka M, Socha B, Mannelli C, Skarzynski DJ (2014) Is adenomyosis a problem in reproduction and fertility? Pol J Vet Sci 17:187–194. https://doi.org/10.2478/pjvs-2014-0028

    Article  CAS  PubMed  Google Scholar 

  4. Exacoustos C, Manganaro L, Zupi E (2014) Imaging for the evaluation of endometriosis and adenomyosis. Best Pract Res Clin Obstet Gynaecol 28:655–681. https://doi.org/10.1016/j.bpobgyn.2014.04.010

    Article  PubMed  Google Scholar 

  5. Zhang Y, Zhou L, Li TC, Duan H, Yu P, Wang HY (2014) Ultrastructural features of endometrial-myometrial interface and its alteration in adenomyosis. Int J Clin Exp Pathol 7:1469–1477

    PubMed  PubMed Central  Google Scholar 

  6. Garcia L, Isaacson K (2011) Adenomyosis: review of the literature. J Minim Invasive Gynecol 18:428–437. https://doi.org/10.1016/j.jmig.2011.04.004

    Article  PubMed  Google Scholar 

  7. Yuan H, Zhang S (2019) Malignant transformation of adenomyosis: literature review and meta-analysis. Arch Gynecol Obstet 299:47–53. https://doi.org/10.1007/s00404-018-4991-2

    Article  PubMed  Google Scholar 

  8. Taran FA, Stewart EA, Brucker S (2013) Adenomyosis: epidemiology, risk factors, clinical phenotype and surgical and interventional alternatives to hysterectomy. Geburtshilfe Frauenheilkd 73:924–931. https://doi.org/10.1055/s-0033-1350840

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Sun Y, Xun K, Wang Y, Chen X (2009) A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anticancer Drugs 20:757–769. https://doi.org/10.1097/CAD.0b013e328330d95b

    Article  CAS  PubMed  Google Scholar 

  10. He W, Wang B, Zhuang Y, Shao D, Sun K, Chen J (2012) Berberine inhibits growth and induces G1 arrest and apoptosis in human cholangiocarcinoma QBC939 cells. J Pharmacol Sci 119:341–348. https://doi.org/10.1254/jphs.12052fp

    Article  CAS  PubMed  Google Scholar 

  11. Liu Q, Xu X, Zhao M, Wei Z, Li X, Zhang X, Liu Z, Gong Y, Shao C (2015) Berberine induces senescence of human glioblastoma cells by downregulating the EGFR-MEK-ERK signaling pathway. Mol Cancer Ther 14:355–363. https://doi.org/10.1158/1535-7163.MCT-14-0634

    Article  CAS  PubMed  Google Scholar 

  12. Dong J, Zuo Z, Yan W, Liu W, Zheng Q, Liu X (2019) Berberine ameliorates diabetic neuropathic pain in a rat model: involvement of oxidative stress, inflammation, and mu-opioid receptors. Naunyn Schmiedebergs Arch Pharmacol 392:1141–1149. https://doi.org/10.1007/s00210-019-01659-6

    Article  CAS  PubMed  Google Scholar 

  13. Yang S, Yu Z, Sun W, Jiang C, Ba X, Zhou Q, Xiong D, Xiao L, Deng Q, Hao Y (2020) The antiviral alkaloid berberine ameliorates neuropathic pain in rats with peripheral nerve injury. Acta Neurol Belg 120:557–564. https://doi.org/10.1007/s13760-018-1006-9

    Article  PubMed  Google Scholar 

  14. Liu L, Luo N, Guo J, Xie Y, Chen L, Cheng Z (2018) Berberine inhibits growth and inflammatory invasive phenotypes of ectopic stromal cells: imply the possible treatment of adenomyosis. J Pharmacol Sci 137:5–11. https://doi.org/10.1016/j.jphs.2017.12.001

    Article  CAS  PubMed  Google Scholar 

  15. Liu X, Guo SW (2011) Valproic acid alleviates generalized hyperalgesia in mice with induced adenomyosis. J Obstet Gynaecol Res 37:696–708. https://doi.org/10.1111/j.1447-0756.2011.01655.x

    Article  CAS  PubMed  Google Scholar 

  16. Nie J, Liu X (2017) Quercetin alleviates generalized hyperalgesia in mice with induced adenomyosis. Mol Med Rep 16:5370–5376. https://doi.org/10.3892/mmr.2017.7238

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Ye J, Cai X, Wang D, Zhang F, Wang Z, Cao M, Pang Z, Yang J, Yan H, Li J, Cao P, Hu C (2020) Shi Xiao San ameliorates the development of adenomyosis in an ICR mouse model. Exp Ther Med 20:2845–2855. https://doi.org/10.3892/etm.2020.8994

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Zhu B, Chen Y, Zhang H, Liu X, Guo SW (2015) Resveratrol reduces myometrial infiltration, uterine hyperactivity, and stress levels and alleviates generalized hyperalgesia in mice with induced adenomyosis. Reprod Sci 22:1336–1349. https://doi.org/10.1177/1933719115572479

    Article  CAS  PubMed  Google Scholar 

  19. Bergeron C, Amant F, Ferenczy A (2006) Pathology and physiopathology of adenomyosis. Best Pract Res Clin Obstet Gynaecol 20:511–521. https://doi.org/10.1016/j.bpobgyn.2006.01.016

    Article  PubMed  Google Scholar 

  20. Tsui KH, Lee WL, Chen CY, Sheu BC, Yen MS, Chang TC, Wang PH (2014) Medical treatment for adenomyosis and/or adenomyoma. Taiwan J Obstet Gynecol 53:459–465. https://doi.org/10.1016/j.tjog.2014.04.024

    Article  PubMed  Google Scholar 

  21. Ueda M, Yamashita Y, Takehara M, Terai Y, Kumagai K, Ueki K, Kanda K, Yamaguchi H, Akise D, Hung YC, Ueki M (2002) Survivin gene expression in endometriosis. J Clin Endocrinol Metab 87:3452–3459. https://doi.org/10.1210/jcem.87.7.8682

    Article  CAS  PubMed  Google Scholar 

  22. Nezhat F, Cohen C, Rahaman J, Gretz H, Cole P, Kalir T (2002) Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts. Cancer 94:2935–2940. https://doi.org/10.1002/cncr.10566

    Article  CAS  PubMed  Google Scholar 

  23. Yang JH, Wu MY, Chen CD, Chen MJ, Yang YS, Ho HN (2007) Altered apoptosis and proliferation in endometrial stromal cells of women with adenomyosis. Hum Reprod 22:945–952. https://doi.org/10.1093/humrep/del493

    Article  CAS  PubMed  Google Scholar 

  24. Schwartz ES, La JH, Scheff NN, Davis BM, Albers KM, Gebhart GF (2013) TRPV1 and TRPA1 antagonists prevent the transition of acute to chronic inflammation and pain in chronic pancreatitis. J Neurosci 33:5603–5611. https://doi.org/10.1523/JNEUROSCI.1806-12.2013

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Han AM, Heo H, Kwon YK (2012) Berberine promotes axonal regeneration in injured nerves of the peripheral nervous system. J Med Food 15:413–417. https://doi.org/10.1089/jmf.2011.2029

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Rezaee R, Monemi A, SadeghiBonjar MA, Hashemzaei M (2019) Berberine alleviates paclitaxel-induced neuropathy. J Pharmacopuncture 22:90–94. https://doi.org/10.3831/KPI.2019.22.011

    Article  PubMed  PubMed Central  Google Scholar 

  27. Ni W, Zheng X, Hu L, Kong C, Xu Q (2021) Preventing oxaliplatin-induced neuropathic pain: Using berberine to inhibit the activation of NF-kappaB and release of pro-inflammatory cytokines in dorsal root ganglions in rats. Exp Ther Med 21:135. https://doi.org/10.3892/etm.2020.9567

    Article  CAS  PubMed  Google Scholar 

  28. He Q, Mei D, Sha S, Fan S, Wang L, Dong M (2017) ERK-dependent mTOR pathway is involved in berberine-induced autophagy in hepatic steatosis. J Mol Endocrinol 59:X1. https://doi.org/10.1530/JME-16-0139e

    Article  PubMed  Google Scholar 

  29. Kong WJ, Zhang H, Song DQ, Xue R, Zhao W, Wei J, Wang YM, Shan N, Zhou ZX, Yang P, You XF, Li ZR, Si SY, Zhao LX, Pan HN, Jiang JD (2009) Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression. Metabolism 58:109–119. https://doi.org/10.1016/j.metabol.2008.08.013

    Article  CAS  PubMed  Google Scholar 

  30. Croce CM, Reed JC (2016) Finally, an apoptosis-targeting therapeutic for cancer. Cancer Res 76:5914–5920. https://doi.org/10.1158/0008-5472.CAN-16-1248

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This study was funded by the Basic Public Research Project of Zhejiang Province (LGF19H040014).

Author information

Authors and Affiliations

Authors

Contributions

XS project development, data collection, manuscript editing; HZ project development, data management, manuscript editing; YC, MG, CZ, LH, QP, TL, YL data collection and analysis; BZ manuscript writing and review, data analysis.

Corresponding authors

Correspondence to Xiaolu Shen or Hongping Zhang.

Ethics declarations

Conflict of interest

The authors declare that they have no known conflicts of interest.

Ethical approval

Animal research was approved by the institutional animal care and use committee of Wenzhou People’s Hospital.

Consent to participate

Not applicable.

Consent for publication

All authors reviewed the results and approved the final version of the manuscript.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhu, B., Chen, Y., Guo, M. et al. Berberine attenuates hyperalgesia in mice with adenomyosis. Arch Gynecol Obstet 306, 115–125 (2022). https://doi.org/10.1007/s00404-022-06438-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-022-06438-y

Keywords

Navigation